Rice Hall James & Associates LLC acquired a new position in Teleflex Incorporated (NYSE:TFX – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 4,558 shares of the medical technology company’s stock, valued at approximately $578,000.
Other hedge funds have also recently made changes to their positions in the company. Kelleher Financial Advisors bought a new stake in Teleflex in the second quarter worth approximately $25,000. Banque Cantonale Vaudoise boosted its holdings in shares of Teleflex by 82.5% during the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after buying an additional 113 shares in the last quarter. UMB Bank n.a. boosted its holdings in shares of Teleflex by 57.1% during the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after buying an additional 113 shares in the last quarter. Kestra Advisory Services LLC acquired a new stake in shares of Teleflex during the 4th quarter worth approximately $45,000. Finally, Hantz Financial Services Inc. grew its position in shares of Teleflex by 40.5% during the 4th quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company’s stock worth $48,000 after buying an additional 113 shares during the period. 95.62% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on TFX shares. BMO Capital Markets began coverage on shares of Teleflex in a research note on Wednesday, July 8th. They issued an “outperform” rating and a $159.00 price objective for the company. UBS Group raised their price target on shares of Teleflex from $145.00 to $158.00 and gave the stock a “neutral” rating in a report on Tuesday, August 11th. Zacks Research raised shares of Teleflex from a “strong sell” rating to a “hold” rating in a research note on Tuesday, April 28th. Raymond James Financial reiterated an “outperform” rating and set a $150.00 price objective on shares of Teleflex in a report on Friday, May 8th. Finally, Piper Sandler reissued an “overweight” rating and set a $169.00 price objective (up from $160.00) on shares of Teleflex in a research report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $151.80.
Teleflex Price Performance
Shares of NYSE:TFX opened at $132.26 on Wednesday. Teleflex Incorporated has a twelve month low of $100.18 and a twelve month high of $145.00. The stock’s 50 day moving average is $132.33 and its 200-day moving average is $124.20. The company has a quick ratio of 2.12, a current ratio of 2.60 and a debt-to-equity ratio of 0.94. The firm has a market capitalization of $5.60 billion, a price-to-earnings ratio of -5.68, a PEG ratio of 0.91 and a beta of 0.81.
Teleflex (NYSE:TFX – Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.48. The business had revenue of $570.33 million during the quarter, compared to the consensus estimate of $559.59 million. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. Teleflex’s revenue was up 28.9% compared to the same quarter last year. During the same quarter last year, the firm posted $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Sell-side analysts forecast that Teleflex Incorporated will post 7.26 EPS for the current fiscal year.
Teleflex Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Friday, August 14th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, August 14th. Teleflex’s dividend payout ratio (DPR) is currently -5.84%.
About Teleflex
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
Featured Stories
- Five stocks we like better than Teleflex
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
